Commentary Archive RSS

Helix Wind Corp. (OTCBB: HLWX) Enters into Strategic Relationship with Synergy California LP

Company to Deploy Small Wind Turbines for Oklahoma Medical Research Foundation San Diego, Calif.-based Helix Wind Corp. (OTCBB: HLWX) recently announced its joint distribution agreement with Synergy California LP for deployment of small wind vertical axis turbines manufactured by Helix Wind. In a new release yesterday, Helix Wind stated the agreement represents the first major [...]

ZAP (OTCBB: ZAAP) – Focusing on U.S. Production amid Renewed Interest for Alternative Fuel Vehicles

ZAP completes electric pickup engineering initiative, manufactured and built in the United States Santa Rosa, Calif.-headquartered ZAP (OTCBB: ZAAP), an alternative energy pioneer, recently announced the completion of a U.S. made electric pickup engineering project, an initiative seen to conform with its ongoing efforts to restructure its operations to focus on national production. According to [...]

Anadigics (Nasdaq: ANAD) Awarded with Four New Patents for its Power Amplifier Design

Company’s New Power Amplifier Technology Cuts Consumption up to 75% Anadigics Inc. (Nasdaq: ANAD), recently announced it was granted four patents from the U.S. Patent and Trademark Office for novel advancements in design and development of radio frequency power amplifier technology. The new patents involve the improvement of handset efficiency at lower power levels, which [...]

Northern Explorations (OTCBB: NXPN) Acquires Stake in Texas Natural Gas Property

Company’s Acquired Working Interest is Located in Historically Gas-Rich Region; Company believes Natural Gas Prices will continue to Rise as Economy Heals Northern Exploration Ltd. (OTCBB: NXPN), a natural resources exploration company, recently announced its execution of a definitive agreement to acquire a working interest in the “Ozona Gas Project” from Swiss-based Dominus Energy AG. [...]

Allos Therapeutics (OTCBB: ALTH) announces Favorable Outcome of Phase II PTCL Trial to Treat Rare Blood Cancer

Allos Therapeutics announced results this weekend of its phase II PROPEL study of the company’s promising new anti-blood cancer drug pralatrexate. The development of pralatrexate is hoped to treat patients with a rare but aggressive form of blood cancer called peripheral T-cell lymphoma (PTCL). Allos presented its phase II results of pralatrexate this past weekend [...]

KANA Software Inc. (OTCBB: KANAE) Posts Q1 2009 Financial Results; Sees Strong Q2 Earnings

Menlo Park, Calif.-headquartered KANA Software, provider of award-winning solutions for mastering the multi-channel service experience, recently announced its financial results for the first quarter ended March 31, 2009. KANA Software Inc. (OTCBB: KANAE) posted revenue of $10.9 million, below $18.3 million it posted in the same period last year. Its non-GAAP net loss came in [...]

On Track Innovations (Nasdaq: OTIV): Potential Lures Investors Through Growing Pains

Smart-card technology company On Track Innovations posts Q1 increase in revenue and highlights its introduction into Homeland Security issues. Fort Lee, N.J.-based On Track Innovations Ltd. (Nasdaq: OTIV), a designer, developer and marketer of secure contactless microprocessor-based smart card technology, posted its fiscal 2009 first-quarter financial results. The company showed improvement from the same quarter [...]

Surprise Earnings Release Drives Shares of Synovis Life Technologies (Nasdaq: SYNO)

Synovis posts a 60% increase in second-quarter profit and 19% increase in revenue; Thompson Reuter Analysts maintain Hold rating. Shares of medical device maker Synovis Life Technologies (Nasdaq: SYNO) are continuing a third day of active trading following the companies stellar financial results for its second-quarter results and analyst expectations that the company will perform [...]

International Stem Cell (OTCBB: ISCO) Optimistic Following Positive Pre-Clinical Trial Results to Improve PRK Laser Surgery

Company’s corrective optical laser surgery garners desirable results in first-stage animal trials; continued development and advancement lead the technology one step closer to FDA approval. International Stem Cell Corp., a “parthenogenetic” stem-cell research company, recently announced it received favorable results from animal trials conducted to improve photorefractive keratectomy (PRK), a corrective laser surgery offering as [...]

Power3 Medical Products Inc. (OTCBB: PWRM) Advances Blood Serum Biomarker Test for Alzheimer’s Disease

Company says initial phase of clinical validation trials of NuroPro® AD blood test shows successful diagnoses of different forms of Alzheimer’s, including high-risk patients. Power3 Medical Products, a leading proteomics company, specializes in the development and commercialization of diagnostic tests for early detection of breast cancer and neurodegenerative diseases. The company is currently conducting a [...]